What new identifying factors are making a difference for lung cancer patients? Patient Power founder Andrew Schorr interviewed lung cancer expert Dr. Rebecca Heist, hematologist/oncologist at Massachusetts General Hospital, asking her opinion on the expanding armamentarium. Dr. Heist discusses multiple dynamics including targeted therapies, inhibitors, newly discovered targets, immunotherapies, and resistance therapies aimed at mutations.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo
Advertisement